Dashboard
Manage Tickers

MNMDMind Medicine (MindMed) Inc.

Nasdaq mindmed.co


$ 8.11 $ -0.27 (-3.22 %)    

Friday, 02-Aug-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 447.95 $ -10.91 (-2.37 %)
DIA $ 397.31 $ -6.10 (-1.51 %)
SPY $ 532.92 $ -10.11 (-1.86 %)
TLT $ 98.17 $ 2.97 (3.12 %)
GLD $ 225.36 $ -0.43 (-0.19 %)
$ 8.11
$ 8.09 x 100
$ 8.11 x 205
-- - --
$ 2.41 - $ 12.22
831,410
na
388.15M
$ 7.41
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 03-09-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-28-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-mind-medicine-maintains-35-price-target
HC Wainwright & Co. Reiterates Buy on Mind...
07/31/2024 12:11:05

HC Wainwright & Co. analyst Patrick Trucchio reiterates Mind Medicine (NASDAQ:MNMD) with a Buy and maintains $35 price t...

roth-mkm-maintains-buy-on-mind-medicine-maintains-36-price-target
Roth MKM Maintains Buy on Mind Medicine, M...
07/24/2024 15:21:47

Roth MKM analyst Jason Wittes maintains Mind Medicine (NASDAQ:MNMD) with a Buy and maintains $36 price target.

mindmed-announces-patent-covering-mm120-orally-disintegrating-tablet
MindMed Announces PAtent Covering MM120 Or...
07/17/2024 11:04:28

Core News & Articles
'MDMA Therapy Gets Support From Prominent ...
07/16/2024 18:51:34

https://www.greenmarketreport.com/mdma-therapy-gets-support-from-prominent-research-group-as-fda-weighs-action/ The paper noted...

Core News & Articles
'California Legislature Approves Bill To B...
07/08/2024 16:55:17

https://www.marijuanamoment.net/california-legislature-approves-bill-to-break-psychedelics-research-logjam-sending-it-to-governor/

mindmed-to-be-included-in-russell-2000-and-russell-3000-indexes-effective-today
MindMed To Be Included In Russell 2000 And...
06/28/2024 11:13:54

groundbreaking-fentanyl-vaccine-being-developed-to-prevent-fatal-overdoses-startup-secures-10m
Groundbreaking Fentanyl Vaccine Being Deve...
06/26/2024 22:58:07

The initiative focuses on commercializing academic research aimed at preventing deadly fentanyl from reaching the brain.

cantor-fitzgerald-reiterates-overweight-on-mind-medicine
Cantor Fitzgerald Reiterates Overweight on...
06/21/2024 16:31:46

Cantor Fitzgerald analyst Charles Duncan reiterates Mind Medicine (NASDAQ:MNMD) with a Overweight.

mindmed-reports-completion-of-end-of-phase-2-meeting-with-fda-says-reached-alignment-on-phase-3-development-strategy-for-mm120-in-generalized-anxiety-disorder
MindMed Reports Completion Of End-of-phase...
06/20/2024 11:13:34

Rob Barrow, Chief Executive Officer of MindMed, said, "This marks a significant milestone for MindMed and for the millions ...

Core News & Articles
'Oregon's First-In-Nation Psilocybin Indus...
06/12/2024 18:07:09

https://www.marijuanamoment.net/oregons-first-in-nation-psilocybin-industry-is-struggling-to-find-paying-customers-a-year-after...

psychedelic-stocks-trip-up-after-fda-advisors-reject-mdma-for-ptsd-treatment
Psychedelic Stocks Trip Up After FDA Advis...
06/05/2024 19:26:42

FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit,...

why-lands-end-shares-are-trading-lower-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Lands' End Shares Are Trading Lower? H...
06/05/2024 17:04:26

whats-going-on-with-mindmed-and-psychedelic-stocks
What's Going On With MindMed And Psychedel...
06/05/2024 14:58:55

Mind Medicine (MindMed) shares are trading lower Wednesday after a Food and Drug Administration (FDA) panel rejected the approv...

rbc-capital-reiterates-outperform-on-mind-medicine-maintains-22-price-target
RBC Capital Reiterates Outperform on Mind ...
06/05/2024 14:47:20

RBC Capital analyst Brian Abrahams reiterates Mind Medicine (NASDAQ:MNMD) with a Outperform and maintains $22 price target.

douyu-international-posts-q1-results-joins-annexon-dollar-tree-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
DouYu International Posts Q1 Results, Join...
06/05/2024 12:07:39

why-stitch-fix-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket
Why Stitch Fix Shares Are Trading Higher B...
06/05/2024 09:27:25

baird-initiates-coverage-on-mind-medicine-with-outperform-rating-announces-price-target-of-27
Baird Initiates Coverage On Mind Medicine ...
05/28/2024 20:25:45

Baird analyst Joel Beatty initiates coverage on Mind Medicine (NASDAQ:MNMD) with a Outperform rating and announces Price Tar...

hc-wainwright--co-reiterates-buy-on-mind-medicine-maintains-35-price-target
HC Wainwright & Co. Reiterates Buy on Mind...
05/24/2024 16:09:42

HC Wainwright & Co. analyst Patrick Trucchio reiterates Mind Medicine (NASDAQ:MNMD) with a Buy and maintains $35 price t...

Core News & Articles
'Top Federal Drug Official Says There's 'T...
05/24/2024 15:47:04

https://www.marijuanamoment.net/top-federal-drug-official-says-theres-tremendous-excitement-around-psych

cannabis-meets-prescription-drugs-steroids-and-ketamine-in-schedule-iii-what-it-means-key-stocks-to-watch
Cannabis Meets Prescription Drugs, Steroid...
05/18/2024 14:19:14

President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)